Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
Genetics Laboratory Shodair Children's Hospital United States | 1 | 1 |
|
GENETIX Centro de Investigación en Genética Humana y Reproductiva Colombia | 2 | 1 |
|
Molecular Genetics Laboratory London Health Sciences Centre Canada | 1 | 1 |
|
Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital United States | 2 | 1 |
|
F5 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 5 | 1 |
|
Centogene US, LLC - The Rare Disease Company United States | 110 | 112 |
|
Centogene US, LLC - The Rare Disease Company United States | 829 | 848 |
|
Centogene US, LLC - The Rare Disease Company United States | 669 | 688 |
|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 734 | 744 |
|
F5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Pharmacogenomics Panel Invitae United States | 43 | 37 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 342 | 156 |
|
Invitae United States | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.